Aleksi Lahti

1.7k citations

17 papers · 1.5k indexed · 1 hit paper · h-index 15

Co-authors: Hannu Kankaanranta Riku Korhonen Eeva Moilanen Mari Hämäläinen Ulla Jalonen Riina Nieminen Mark A. Giembycz Richard G. Knowles
Topics: Nitric Oxide and Endothelin Effects (8 papers)Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers)Inflammatory mediators and NSAID effects (3 papers)
Cited by: Toxicology Immunology Pharmacology
Journals: PLoS ONE Biochemical Journal Journal of Allergy and Clinical Immunology
Partner nations: Finland Netherlands Canada

In The Last Decade

Aleksi Lahti

16 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nitric Oxide Production and Signaling in Inflammation

2005 805 citations Riku Korhonen, Aleksi Lahti et al. Current Drug Targets - Inflammation & Allergy profile →

Peers

Countries citing papers authored by Aleksi Lahti

Since Specialization

Citations

This map shows the geographic impact of Aleksi Lahti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleksi Lahti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleksi Lahti more than expected).

Fields of papers citing papers by Aleksi Lahti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aleksi Lahti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleksi Lahti. The network helps show where Aleksi Lahti may publish in the future.

Co-authorship network of co-authors of Aleksi Lahti

This figure shows the co-authorship network connecting the top 25 collaborators of Aleksi Lahti. A scholar is included among the top collaborators of Aleksi Lahti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleksi Lahti. Aleksi Lahti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Pupils’ experience of noise in two acoustically different classrooms 2023 ·Facilities ·Jenni Radun,(unknown),Aleksi Lahti,Marjaana Veermans,(unknown),Valtteri Hongisto	5
2	Generation of student interest in an inquiry-based mobile learning environment 2017 ·Frontline Learning Research ·(unknown),Marjaana Veermans,Aleksi Lahti,Koen Veermans	14
3	Tumour Necrosis Factor-α Regulates Human Eosinophil Apoptosis via Ligation of TNF-Receptor 1 and Balance between NF-κB and AP-1 2014 ·PLoS ONE ·Hannu Kankaanranta,Pinja Ilmarinen,Xianzhi Zhang,Ian M. Adcock,Aleksi Lahti,Peter J. Barnes,Mark A. Giembycz,Mark A. Lindsay,Eeva Moilanen	49
4	Regulation of inducible nitric oxide synthase expression and nitric oxide production by mitogen-activated protein kinase pathways 2012 ·Trepo - Institutional Repository of Tampere University ·Aleksi Lahti	0
5	Inhibition of p38 mitogen-activated protein kinase enhances c-Jun N-terminal kinase activity: Implication in inducible nitric oxide synthase expression 2006 ·BMC Pharmacology ·Aleksi Lahti,Outi Sareila,Hannu Kankaanranta,Eeva Moilanen	33
6	JNK inhibitor SP600125 reduces COX-2 expression by attenuating mRNA in activated murine J774 macrophages 2006 ·International Immunopharmacology ·Riina Nieminen,Aleksi Lahti,Ulla Jalonen,Hannu Kankaanranta,Eeva Moilanen	41
7	Nitric Oxide Production and Signaling in Inflammationbreakdown → 2005 ·Current Drug Targets - Inflammation & Allergy ·Riku Korhonen,Aleksi Lahti,Hannu Kankaanranta,Eeva Moilanen	805
8	Inhibitors of Mitogen‐Activated Protein KinasesDownregulate COX‐2 Expression in Human Chondrocytes 2005 ·Mediators of Inflammation ·Riina Nieminen,(unknown),Aleksi Lahti,Katriina Vuolteenaho,Ulla Jalonen,Hannu Kankaanranta,Mary B. Goldring,Eeva Moilanen	56
9	TGFβ inhibits IL-1 -induced iNOS expression and NO production in immortalized chondrocytes 2005 ·Inflammation Research ·Katriina Vuolteenaho,Teemu Moilanen,Ulla Jalonen,Aleksi Lahti,R. Nieminen,Henk M. van Beuningen,P.M. van der Kraan,Eeva Moilanen	25
10	Inhibition of tristetraprolin expression by dexamethasone in activated macrophages 2005 ·Biochemical Pharmacology ·Ulla Jalonen,Aleksi Lahti,Riku Korhonen,Hannu Kankaanranta,Eeva Moilanen	34
11	c-Jun NH2-Terminal Kinase Inhibitor Anthra(1,9-cd)pyrazol-6(2H)-one Reduces Inducible Nitric-Oxide Synthase Expression by Destabilizing mRNA in Activated Macrophages 2003 ·Molecular Pharmacology ·Aleksi Lahti,Ulla Jalonen,Hannu Kankaanranta,Eeva Moilanen	76
12	Regulation of eosinophil apoptosis by nitric oxide: Role of c-Jun-N-terminal kinase and signal transducer and activator of transcription 5 2003 ·Journal of Allergy and Clinical Immunology ·Xianzhi Zhang,(unknown),Eeva Moilanen,Aleksi Lahti,Mari Hämäläinen,Mark A. Giembycz,Peter J. Barnes,Mark A. Lindsay,Hannu Kankaanranta	41
13	P38 mitogen-activated protein kinase inhibitor SB203580 has a bi-directional effect on iNOS expression and NO production 2002 ·European Journal of Pharmacology ·Aleksi Lahti,Hannu Kankaanranta,Eeva Moilanen	30
14	Calcineurin inhibitors, cyclosporin A and tacrolimus inhibit expression of inducible nitric oxide synthase in colon epithelial and macrophage cell lines 2002 ·European Journal of Pharmacology ·Mari Hämäläinen,Aleksi Lahti,Eeva Moilanen	42
15	Dexamethasone Inhibits Inducible Nitric-Oxide Synthase Expression and Nitric Oxide Production by Destabilizing mRNA in Lipopolysaccharide-Treated Macrophages 2002 ·Molecular Pharmacology ·Riku Korhonen,Aleksi Lahti,Mari Hämäläinen,Hannu Kankaanranta,Eeva Moilanen	155
16	Bi-directional effects of the elevation of intracellular calcium on the expression of inducible nitric oxide synthase in J774 macrophages exposed to low and to high concentrations of endotoxin 2001 ·Biochemical Journal ·Riku Korhonen,Hannu Kankaanranta,Aleksi Lahti,(unknown),Richard G. Knowles,Eeva Moilanen	35
17	Bi-directional effects of the elevation of intracellular calcium on the expression of inducible nitric oxide synthase in J774 macrophages exposed to low and to high concentrations of endotoxin 2001 ·Biochemical Journal ·(unknown),Hannu Kankaanranta,Aleksi Lahti,(unknown),Richard G. Knowles,Eeva Moilanen	25

About Aleksi Lahti

Aleksi Lahti is a scholar working on Physiology, Immunology and Toxicology, having authored 17 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (8 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Toxicology (59 citations), Immunology (344 citations) and Pharmacology (121 citations). Aleksi Lahti has collaborated with scholars based in Finland, Netherlands and Canada. Frequent co-authors include Hannu Kankaanranta, Riku Korhonen, Eeva Moilanen, Eeva Moilanen, Mari Hämäläinen, Ulla Jalonen, Riina Nieminen, Mark A. Giembycz, Richard G. Knowles and Peter J. Barnes. Their work appears in journals such as PLoS ONE, Biochemical Journal and Journal of Allergy and Clinical Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact